✦ LIBER ✦

Phase II trial of adjuvant pelvic radiation “sandwiched” between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma

✍ Scribed by Mark H. Einstein; Merieme Klobocista; June Y. Hou; Stephen Lee; Subhakar Mutyala; Keyur Mehta; Laura L. Reimers; Dennis Y.-S. Kuo; Gloria S. Huang; Gary L. Goldberg

Book ID: 113963483
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 327 KB
Volume: 124
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.10.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of adjuvant pelvic radiat

Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma

✍ Mark H. Einstein; Marina Frimer; Dennis Y.-S. Kuo; Laura L. Reimers; Keyur Mehta 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Prospective phase II trial of adjuvant p

Prospective phase II trial of adjuvant pelvic radiation “sandwiched” between paclitaxel and carboplatin combination chemotherapy in women with uterine papillary serous carcinoma

✍ M. Einstein; M. Frimer; R. Phaeton; L. Reimers; K. Mehta; S. Mutyala; D. Kuo; G. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 110 KB

A phase II trial of cisplatin, ifosfamid

A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets

✍ Lois M Ramondetta; Thomas W Burke; Anuja Jhingran; Rosemarie Schmandt; Michael W 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 367 KB

8001 Randomized multicenter phase II tri

8001 Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Co-operative Oncology Group (HeCOG) study

✍ Mountzios, G.; Dimopoulos, M.A.; Bamias, A.; Vourli, G.; Kalofonos, H.; Aravanti 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB